Dr. Asad Dean, MD

Dr. Dean practices at Texas Oncology PA in Fort Worth, Texas.

Dr. Dean's NPI, 1760441885, was assigned on March 18, 2006. Dr. Dean graduated from UT Southwestern Medical Center in 1997. Dr. Dean's Texas license number on file is L1557.

Dr. Dean's primary practice is Texas Oncology PA, at 500 S Henderson St, Fort Worth, TX 76104 in Tarrant County. The practice phone is (972) 997-8000.

Dr. Dean's primary practice is Texas Oncology PA in Fort Worth, Texas. Dr. Dean is also affiliated with Texas Health Fort Worth. The medical group on file is Texas Oncology. Dmand AI also links Dr. Dean to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dean practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dean's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dean is board certified in medical oncology by the American Board of Internal Medicine. Dr. Dean has a license on file in Texas.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Dean treats.

CMS data shows 42,937 Medicare services from Dr. Dean across 59 procedure codes in 2024, for 581 Medicare patients. Medicare paid $720,711 for them.

CMS counts 581 Medicare patients who saw Dr. Dean in 2024. The largest group is 65 to 74, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dean's median patient age at 70, with 59% women.

In 2024, Dr. Dean wrote 1,281 Medicare Part D claims for 248 patients. 78% of them were for generic drugs. CMS names the drug for 968 of them, across 33 drugs with 11 or more claims each, at $2,755,355 in total drug cost. In 2023, CMS named 820 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Dean for performance year 2024, reported through an alternative payment model (APM). Dr. Dean accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dean as offering telehealth.

Dmand AI links 1 paper to Dr. Dean. Dr. Dean's most frequent co-author is Jonathan Edwards Dowell, MD.

CMS Open Payments shows 2,653 general payments to Dr. Dean from 63 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Pharmacyclics LLC, An AbbVie Company paid the most, $607,576.

Dmand AI lists 1 award for Dr. Dean, most recently CMS Stage 1 2012 in 2012.

Dr. Dean graduated from UT Southwestern Medical Center in 1997. Dr. Dean is a member of ASCO.

Dr. Dean is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.